Blood protein levels could predict immunotherapy success in common cancers
Knowledge-focused
Recruiting now
This observational study is exploring whether levels of a protein called Galectin-3 in the blood are linked to how well patients with kidney, lung, bladder, or liver cancer respond to immunotherapy drugs (PD-1/PDL-1 inhibitors). Researchers will measure Galectin-3 before each tre…
Sponsor: Daniel Keizman • Aim: Knowledge-focused
Last updated May 26, 2026 07:08 UTC